VistaGen Therapeutics (VTGN) Stock Chart & Stock Price History $2.92 +0.05 (+1.74%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.90 -0.02 (-0.68%) As of 08/1/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VistaGen Therapeutics Stock Price Performance The VistaGen Therapeutics (VTGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 8.18%, with a year-to-date return of -1.02%. In the past month, the stock has increased 43.14%, reflecting recent market activity. As of the latest close, VistaGen Therapeutics traded at $2.92 with a market cap of $85.15 million and volume of 329,032 shares. Five years ago, the stock traded at a split-adjusted price of $27.90, representing a 89.53% decrease over that period. At the time, it had a market cap of $52.11 million and a volume of 58,869 shares. Receive VTGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VistaGen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.46%1 Month Performance+43.14%3 Month Performance+22.69%Year-To-Date Performance-1.02%1 Year Performance-8.18%5 Year Performance-89.53% VTGN Stock Chart for Saturday, August, 2, 2025 VTGN Chart by TradingView VistaGen Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$2.87$2.92+1.74%$2.94$2.70329,032 shs$85.15 million07/31/2025$2.95$2.87-2.71%$3.05$2.82372,301 shs$83.68 million07/30/2025$3.06$2.95-3.59%$3.15$2.90401,834 shs$86.02 million07/29/2025$3.19$3.06-4.08%$3.33$2.93770,423 shs$89.23 million07/28/2025$3.08$3.19+3.57%$3.31$3.001.05 million shs$93.01 million07/25/2025$2.71$3.08+13.65%$3.24$2.661.18 million shs$89.81 million07/24/2025$2.73$2.71-0.73%$2.79$2.65190,312 shs$79.02 million07/23/2025$2.54$2.73+7.48%$2.83$2.54594,256 shs$79.61 million07/22/2025$2.55$2.54-0.39%$2.59$2.50241,271 shs$74.06 million07/21/2025$2.55$2.55$2.67$2.50429,344 shs$74.36 million Get the Latest News and Ratings for VTGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VistaGen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$2.54$2.55+0.39%$2.57$2.45276,000 shs$74.36 million07/17/2025$2.47$2.54+2.83%$2.56$2.40417,009 shs$74.07 million07/16/2025$2.25$2.47+9.78%$2.56$2.27480,451 shs$72.02 million07/15/2025$2.38$2.25-5.46%$2.44$2.25194,283 shs$65.61 million07/14/2025$2.38$2.38$2.44$2.35280,659 shs$69.40 million07/11/2025$2.43$2.38-2.06%$2.44$2.30195,617 shs$69.40 million07/10/2025$2.49$2.43-2.41%$2.54$2.40218,611 shs$70.86 million07/09/2025$2.46$2.49+1.22%$2.63$2.43502,278 shs$72.60 million07/08/2025$2.21$2.46+11.31%$2.62$2.231.31 million shs$71.73 million07/07/2025$2.03$2.21+9.14%$2.26$2.00677,610 shs$64.44 million07/04/2025$2.03$2.03$2.05$1.99107,238 shs$59.05 million07/03/2025$2.04$2.03-0.74%$2.05$1.99107,238 shs$59.05 million07/02/2025$2.01$2.04+1.49%$2.07$2.01179,080 shs$59.49 million07/01/2025$2.00$2.01+0.50%$2.06$1.97168,018 shs$58.61 million Related Companies CADL Stock Price Chart GLUE Stock Price Chart RNAC Stock Price Chart FHTX Stock Price Chart RCKT Stock Price Chart INBX Stock Price Chart ABEO Stock Price Chart AVIR Stock Price Chart ALT Stock Price Chart ALLO Stock Price Chart Receive VTGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VistaGen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VTGN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VistaGen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VistaGen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
